A Comparison of the Effectiveness of Intravenous Immunoglobulin and Plasma Exchange as Preoperative Therapy of Myasthenia Gravis
- 1 March 2008
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Neuromuscular Disease
- Vol. 9 (3), 352-355
- https://doi.org/10.1097/cnd.0b013e3181660807
Abstract
Immunomodulation with plasma exchange is effective in preparing patients for thymectomy. Newer forms of immunomodulation, such as intravenous immunomodulation, require evaluation in this clinical setting. We conducted a retrospective chart review to determine if plasma exchange and intravenous immunoglobulin had comparable effectiveness in the preoperative preparation of patients with myasthenia gravis. The results show that intravenous immunoglobulin may have comparable efficacy in the preoperative preparation of patients with myasthenia gravis and that this therapy is a reasonable alternative to plasma exchange in this clinical setting.Keywords
This publication has 8 references indexed in Scilit:
- IV immunoglobulin in patients with myasthenia gravisNeurology, 2007
- Treatment of Myasthenia Gravis Exacerbation With Intravenous ImmunoglobulinArchives of Neurology, 2005
- Prethymectomy plasmapheresis in myasthenia gravisJournal of Clinical Apheresis, 2005
- Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validityNeurology, 2005
- Impact of minimally invasive trans-cervical thymectomy on outcome in patients with myasthenia gravisEuropean Journal of Cardio-Thoracic Surgery, 2003
- Coagulation abnormalities in serial double‐filtration plasmapheresisJournal of Clinical Apheresis, 2001
- Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravisAnnals of Neurology, 1997
- Myasthenic CrisisArchives of Neurology, 1993